Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multi-Arm Study of Magrolimab in Patients With Solid Tumors

NCT04827576 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT04827576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04827576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multi-Arm Study of Magrolimab in Patients With Solid Tumors
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Terminated
Start date
October 1, 2021
Completion date
October 1, 2024
Enrollment
106 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor